A61L 2300/434
Of enzymes
Official title: of enzymes
A61L2300/434 (Of enzymes) appears on 190 US grants and 359 published applications in this corpus.
Search patents in A61L- Granted patents
- 190
- Published applications
- 359
- Assignees
- 187
- Inventors
- 644
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 3 |
| 2002 | 3 | 6 |
| 2003 | 2 | 15 |
| 2004 | 6 | 18 |
| 2005 | 2 | 18 |
| 2006 | 4 | 20 |
| 2007 | 3 | 12 |
| 2008 | 3 | 13 |
| 2009 | 1 | 10 |
| 2010 | 10 | 20 |
| 2011 | 5 | 9 |
| 2012 | 5 | 13 |
| 2013 | 6 | 8 |
| 2014 | 16 | 18 |
| 2015 | 8 | 36 |
| 2016 | 16 | 17 |
| 2017 | 16 | 12 |
| 2018 | 12 | 23 |
| 2019 | 10 | 13 |
| 2020 | 6 | 9 |
| 2021 | 6 | 15 |
| 2022 | 7 | 12 |
| 2023 | 6 | 10 |
| 2024 | 7 | 14 |
| 2025 | 8 | 8 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Injectable composition and use of said composition12 May 2026US 12,622,863 B2Innate S.R.L.
- Anticoagulant compounds and methods and devices for their use13 Jan 2026US 12,521,258 B2Elixir Medical Corporation
- Subcutaneous biodegradable reservoir device6 Jan 2026US 12,515,027 B2Research Triangle Institute
- Human placental tissue graft products, methods, and apparatuses21 Oct 2025US 12,447,231 B2Cryolife, Inc.
- Methods of treating joint disease, disorders, and conditions with tissue inhibitors of matrix metalloproteinase7 Oct 2025US 12,433,918 B2Prime Merger Sub, LLC
- A suprachoroidal spacer implant to treat glaucoma20 Aug 2026US 2026/0240682 A1The Board of Trustees of the Leland Stanford Junior University
- New Hyaluronan Hydrogels Chemically Crosslinked By MMP Inhibitors23 Jul 2026US 2026/0209395 A1Consorzio Interuniversitario Nazionale Per La Scienza E Tecnologia Dei Materiali
- Verteporfin Containing Silicone Topical Skin Adhesive for Wound Closure and Reduced Scarring30 Apr 2026US 2026/0115352 A1Cilag GmbH International
- Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation5 Feb 2026US 2026/0034270 A1Allergan, Inc.
- Subcutaneous biodegradable reservoir device5 Feb 2026US 2026/0034339 A1Research Triangle Institute
Most cited
By later US patents
- Embolization plugs for blood vessels471US 5,456,693 AVitaphore Corporation · 1995
- Biodegradable matrix and methods for producing same339US 4,703,108 AUniversity of Medicine and Dentistry of New Jersey · 1987
- Biodegradable matrix and methods for producing same314US 4,970,298 AUniversity of Medicine and Dentistry of New Jersey · 1990
- Compositions for efficient release of active ingredients263US 6,716,441 B1The Procter & Gamble Company · 2004
- Enriched plasma derivative for enhancement of wound closure and coverage168US 4,427,651 ASerapharm Michael Stroetmann · 1984